Spanish Red Biotech Pipeline

CIBER

USE OF AN MNK kinase inhibitor for the treatment of Triple-negative breast cancer

Type: Biomarkers / Diagnostic
Therapeutic area: Cancer
Women´s health
Indication: breast cancer
Phase: 1R+D
Studies location: